Sponsor or institution

Clinical trials and research at InventisBio Co., Ltd

• 9Clinical trials
• 2Countries

Newest trials

All recruiting trials (9)

• Testing D-2570 in adults with varying kidney function

  This study tests a single dose of D-2570 in adults aged 18–70 with different levels of kidney function to see how the drug behaves in the body.

  Recruiting Phase 1 InventisBio Co., Ltd · Hefei, Anhui · NCT07715175

• Pharmacokinetics of D-2570 in people with liver impairment and in healthy volunteers

  This study tests how D-2570 moves through and affects the body in adults with liver impairment compared to those with normal liver function.

  Recruiting Phase 1 InventisBio Co., Ltd · Bengbu, Anhui · NCT07715149

• D-2570 in Non-Segmental Vitiligo (Phase 2)

  This study tests whether D-2570 can improve skin discoloration in adults with non-segmental vitiligo compared with a placebo.

  Recruiting Phase 2 InventisBio Co., Ltd · Shanghai, Shanghai Municipality · NCT07625891

• D-2570 in Moderate to Severe Plaque Psoriasis

  This study tests whether D-2570 can safely improve symptoms in adults with moderate to severe plaque psoriasis.

  Recruiting at 3 sites Phase 2 InventisBio Co., Ltd · Birmingham, Alabama and 19 other locations · NCT07489885

• D-2570 oral treatment for adults with moderate to severe plaque psoriasis

  This trial tests whether the oral medicine D-2570 helps adults with moderate to severe plaque psoriasis compared with placebo and an approved oral drug.

  Recruiting Phase 3 InventisBio Co., Ltd · Shanghai, Shanghai Municipality · NCT07326813

• D-2570 treatment for people with active psoriatic arthritis (Phase II)

  This Phase II trial tests whether the investigational medicine D-2570 helps adults with active psoriatic arthritis reduce joint pain and swelling compared with placebo.

  Recruiting Phase 2 InventisBio Co., Ltd · Chengdu, Sichuan · NCT07315061

• D-2570 treatment for active systemic lupus erythematosus

  This trial will test whether daily D-2570 helps adults (18–70) with active systemic lupus erythematosus control their symptoms and disease activity better than a placebo over 48 weeks.

  Recruiting Phase 2 InventisBio Co., Ltd · Linfen, Jiangxi · NCT07311200

• D-2570 treatment for moderate to severe plaque psoriasis

  This trial will try D-2570 versus placebo to see if it helps and is safe for people with moderate to severe plaque psoriasis.

  Recruiting Phase 3 InventisBio Co., Ltd · Beijing, Beijing Municipality · NCT07130604

• Evaluating D-0502 for treating advanced breast cancer

  This study is testing a new drug called D-0502 to see if it works better than the standard treatment for people with advanced breast cancer that is ER-positive and HER2-negative.

  Recruiting at 2 sites Phase 3 InventisBio Co., Ltd · Beijing, Beijing Municipality and 1 other locations · NCT06954961

Quick answers

How many clinical trials run by InventisBio Co., Ltd are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (8 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 3, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →